You are herePharm.D

Pharm.D


Vacancy in Novartis for the post of Clinical Scientifc Expert - I

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Clinical Scientifc Expert - I


Fresher M.Pharm or Pharm.D require as Medical Writer in Medeka Health

Medeka is a professional media group focused on the health sector. We specialize in connecting communities through strong inter-portable channels in print, live events and digital platforms. Our proximal client base includes the pharmaceutical & allied healthcare marketers, medical professionals and patients/consumers.

Post: Medical Writer- Two post


Career as Clinical Scientific Expert II in Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.


Recruitment in Novartis for the post of Pharmacovigilance Expert

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post: Pharmacovigilance Expert


Job for M.Pharm, B.Pharm, M.Sc with MBA, Ph.D, Pharm.D as Group Head DRA AMAC/LACan in Novartis

Novartis (NYSE: NVS) is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.
Headquartered in Basel, Switzerland, Novartis employs nearly 115 000 people in over 140 countries worldwide to help save lives and improve the quality of life. The Group is present in India through Novartis India Limited, listed on the Mumbai Stock Exchange and its wholly owned subsidiaries Novartis Healthcare Private Limited, Sandoz Private Limited and Chiron Behring Vaccines Private Limited.

Post: Group Head DRA AMAC/LACan


Job for PharmD, JD, Ph.D as Global Regulatory Strategist in Pfizer

Founded in 1849, Pfizer is the world's premier biopharmaceutical company taking new approaches to better health. We discover, develop, manufacture and deliver quality, safe and effective prescription medicines to treat and help prevent disease for both people and animals. We also partner with healthcare providers, governments and local communities around the world to expand access to our medicines and to provide better quality health care and health system support. At Pfizer, colleagues in more than 90 countries work every day to help people stay happier and healthier longer and to reduce the human and economic burden of disease worldwide.

Post: Global Regulatory Strategist


Walk in interview for B.Pharm, M.Pharm as Drug Safety Associate in Synowledge

Synowledge is a Global Management Consulting, Technology Services and Outsourcing Company focused in the Life Sciences & Healthcare Industry. With an annual growth rate of 300% and serving clients across 6 global offices (US, EU and Asia Pacific), Synowledge has gained market share to become the leading service provider in its space. Combining unparalleled experience and specialized capabilities within the Life Sciences industry, Synowledge has become a strategic partner with many Top 20 Pharma and Fortune 500 companies. Synowledge's technology solutions and innovative consulting services help life sciences companies reduce cost, accelerate growth and minimize time to market during the drug development lifecycle.

Post: Drug Safety Associate


Recruitment of Technical Associate (TA) under Pharmacovigilance Programme of India (PvPI) for Regional Resource and Training Centre, PGIMER

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage. The institute started in 1962 and Pt Jawahar Lal Nehru inaugurated the hospital now named “Nehru Hospital” on 7th July 1963. The Institute was originally under the Government of undivided Punjab. After the reorganization of the state, the administrative control of the institute passed on to the Union Territory of Chandigarh in November 1966.  The Institute became an autonomous body under the Act of Parliament in 1967 functioning under the Ministry of Health and Family Welfare, Government of India.


Opening for M.Pharm as Lecturer/ Senior Lecturer/ Assistant Professor @ Amrita School of Pharmacy

AMRITA School of Pharmacy is an open green spread developed land with sufficient build up space. new facilities and amenities are added every year to facilitate progress and overall development for the benefit of the students. The college provides state-of-the-art infrastructure support fulfilling all AICTE norms.

Post: Lecturer/ Senior Lecturer/ Assistant Professor


POLYPHARMACY IN GERIATRICS

{ DOWNLOAD AS PDF }

About Authors:
T. Vishnuvaravidyadhar*, M. Sushma, R. Mohanraj, M. Babu  
Department of Pharmacy Practice,
Raghavendra Institute of Pharmaceutical Education & Research, RIPER
K R Palli Cross, Near S.K University,
Anantapuramu District, Andhra Pradesh, INDIA

*vishnuvaravidyadhar@gmail.com

Abstract:
Geriatrics is more prone to higher risks of chronic illness and are using multiple medications in order to lead healthy life. Polypharmacy increases the risk of adverse drug events, as a result changes takes place in physiological, social, physical and functional decline in the body. These rapid physiological changes make elderly patients unable to cope with body stresses. Drug toxicity, side effects and adverse drug reactions appear more frequently and are more life-threatening in elderly patients. Tetracyclins, streptomycin, reserpine, and all barbiturates are to be contraindicated in geriatrics in order to prevent further complications. Polypharmacy is the simultaneous taking of many medications, has been well documented and is a topic of much concern for those looking to improve the quality of care for the elderly. Elderly patients often develop complicated conditions and multi-factorial health states that require extensive pharmacotherapy, sometimes surgery leaving the population at risk for exposure to drug-drug interactions, drug-food interactions and other adverse events. Previously literature states that rate of adverse events are directly proportional to number of drugs taken by the patient. To manage all these complications and to avoid polypharmacy Dose regimen should be simple and drugs should be given in combinations to improve patient compliance.


FIND LATEST JOBS

Subscribe to RSS headline updates from:
Powered by FeedBurner